04/07/2014
Federal Register Notice: FDA is seeking public comment on a proposed collection of information on a generic clearance to collect i...04/07/2014
Federal Register Notice: FDA is seeking comment on a proposed collection of information related to FDA’s Adverse Experience ...04/07/2014
Federal Register Notice: FDA published a document in 2/27 Federal Register on the voluntary withdrawal of approval of NADAs. The d...03/31/2014
Federal Register Notice: FDA is making available a guidance entitled Guidance for the Public, Food and Drug Administration Advisor...03/31/2014
Federal Register Notice: FDA has determined the regulatory review period for Nulojix is 4,479 days for extending a patent which cl...